HealthStream, Inc. (NASDAQ:HSTM) Receives $32.00 Average Price Target from Analysts

Shares of HealthStream, Inc. (NASDAQ:HSTM) have been assigned an average recommendation of “Moderate Buy” from the five brokerages that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $32.00.

HSTM has been the subject of a number of recent analyst reports. Canaccord Genuity Group upped their price objective on HealthStream from $29.00 to $30.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. William Blair restated an “outperform” rating on shares of HealthStream in a research report on Tuesday, February 25th. Finally, JMP Securities reaffirmed a “market perform” rating on shares of HealthStream in a research report on Thursday, February 6th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in HSTM. Copeland Capital Management LLC raised its stake in HealthStream by 17,363.4% in the 4th quarter. Copeland Capital Management LLC now owns 379,306 shares of the technology company’s stock valued at $12,062,000 after acquiring an additional 377,134 shares during the period. Cerity Partners LLC increased its stake in shares of HealthStream by 3,889.2% in the fourth quarter. Cerity Partners LLC now owns 300,070 shares of the technology company’s stock worth $9,534,000 after purchasing an additional 292,548 shares in the last quarter. Norges Bank bought a new stake in shares of HealthStream in the fourth quarter valued at approximately $3,649,000. Vanguard Group Inc. lifted its stake in shares of HealthStream by 3.1% during the 4th quarter. Vanguard Group Inc. now owns 3,055,060 shares of the technology company’s stock valued at $97,151,000 after buying an additional 92,067 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in HealthStream by 47.5% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 221,609 shares of the technology company’s stock worth $7,047,000 after buying an additional 71,379 shares during the period. Institutional investors own 69.58% of the company’s stock.

HealthStream Stock Performance

HealthStream stock opened at $32.28 on Friday. The stock has a market cap of $982.41 million, a PE ratio of 49.66, a price-to-earnings-growth ratio of 4.37 and a beta of 0.37. HealthStream has a fifty-two week low of $23.92 and a fifty-two week high of $34.24. The firm’s 50-day simple moving average is $32.61 and its 200 day simple moving average is $31.44.

HealthStream (NASDAQ:HSTM) last announced its earnings results on Monday, February 24th. The technology company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.03. The firm had revenue of $74.24 million for the quarter, compared to the consensus estimate of $73.55 million. HealthStream had a return on equity of 5.67% and a net margin of 6.84%. During the same quarter in the previous year, the business earned $0.14 EPS. As a group, analysts predict that HealthStream will post 0.63 EPS for the current fiscal year.

HealthStream Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Monday, March 10th were paid a $0.031 dividend. The ex-dividend date was Monday, March 10th. This is a positive change from HealthStream’s previous quarterly dividend of $0.03. This represents a $0.12 annualized dividend and a dividend yield of 0.38%. HealthStream’s payout ratio is presently 18.18%.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.